Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-48.46	-39.76	77.15
Graham Fair Price	88.66	26.86	14.24
PEG	-89.51	0.13	-1.23
Price/Book	15.51	3.10	2.69
Price/Cash Flow	-40.29	98.15	164.37
Prices/Earnings	-66.90	32.37	97.81
Price/Sales	9.87	14.83	13.49
Price/FCF	-40.29	98.15	164.37
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-51.44	-0.23	0.47
Operating Margin	1528.61	-0.52	0.03
ROA	253.37	0.01	< 0.005
ROE	< 0.005	0.02	249.00
ROIC	< 0.005	-0.06	1320.91
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.41	-99.02
Dividends QOQ	< 0.005	< 0.005	-88.11
EBIT QOQ	-0.81	-18.31	-2158.85
EPS QOQ	-0.80	2.52	215.64
FCF QOQ	1.42	0.96	-32.52
Revenue QOQ	< 0.005	0.06	852.97
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	99.45	39.54	-60.24
Days Sales Outstanding (DSO)	60.31	59.17	-1.89
Inventory Turnover	0.91	2.28	151.51
Debt/Capitalization	0.36	0.34	-3.86
Quick Ratio	0.62	0.68	8.86
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	36.22	36.58	0.99
Cash	3.64	4.06	11.54
Capex	-0.13	-0.14	-6.38
Free Cash Flow	0.59	1.16	95.36
Revenue	7.21	7.66	6.18
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.12	1.18	5.33
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.17	-4.90	-56.14
Naive Interpretation	Member

06 - Financial Health · Bad

Rating